News | March 09, 2022
SII’s Covovax approved for 12-17 years age group
The DCGI has already approved Covovax for restricted use in emergency situations in adults on December 28th 2021
The DCGI has already approved Covovax for restricted use in emergency situations in adults on December 28th 2021
The company is investing up to US $ 500 million to produce up to 500 million doses each year for the African continent
JEEN’s portfolio includes a diverse range of specialized active ingredients, botanical extracts, and complexes serving functional applications for skin and hair care
Investment in technology and people and a meaningful industry-academia partnership can fuel the growth of the Indian biopharma sector
New results build on previously reported significant recurrence-free survival (rfs) benefit seen in these patients
Data integrity early warning system assists pharmaceutical clients in proactively identifying and managing data integrity challenges in line with regulatory guidelines
Nystatin and Triamcinolone Acetonide ointment is indicated for the treatment of cutaneous candidiasis
The revolutionary genetic test helps screen common genes associated with hereditary breast and ovarian cancer in women above 18 years of age
AOI is the leading cancer hospital chain of South Asia operating 16 cancer hospitals in the region
Sense anticipates launching Veros Covid-19 in Europe this quarter, initially in Ireland, Benelux and the Nordic regions
Subscribe To Our Newsletter & Stay Updated
